FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring.
Reymundo LozanoCatherine GbekiePaige M SiperShubhika SrivastavaJeffrey M SalandSwathi SethuramLara TangElodie DrapeauYitzchak FrankJoseph D BuxbaumAlexander KolevzonPublished in: Journal of neurodevelopmental disorders (2021)
FOXP1 syndrome is a neurodevelopmental disorder caused by mutations or deletions that disrupt the forkhead box protein 1 (FOXP1) gene, which encodes a transcription factor important for the early development of many organ systems, including the brain. Numerous clinical studies have elucidated the role of FOXP1 in neurodevelopment and have characterized a phenotype. FOXP1 syndrome is associated with intellectual disability, language deficits, autism spectrum disorder, hypotonia, and congenital anomalies, including mild dysmorphic features, and brain, cardiac, and urogenital abnormalities. Here, we present a review of human studies summarizing the clinical features of individuals with FOXP1 syndrome and enlist a multidisciplinary group of clinicians (pediatrics, genetics, psychiatry, neurology, cardiology, endocrinology, nephrology, and psychology) to provide recommendations for the assessment of FOXP1 syndrome.
Keyphrases
- regulatory t cells
- autism spectrum disorder
- intellectual disability
- transcription factor
- case report
- healthcare
- dendritic cells
- endothelial cells
- traumatic brain injury
- primary care
- heart failure
- white matter
- gene expression
- immune response
- genome wide
- small molecule
- binding protein
- working memory
- resting state
- subarachnoid hemorrhage
- blood brain barrier